The Oncology Institute, Inc. (TOI) NASDAQ
4.59
-0.19(-3.97%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.29B |
| Enterprise Value | 3.36B |
| P/E Ratio | -107.39 |
| PEG Ratio | -1.53 |
| Price/Sales Ratio | 0.84 |
| Price/Book Ratio | -286.93 |
| Enterprise/Revenue | 0.83 |
| Enterprise/EBITDA | -14.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.08 |
| Operating Margin | -0.06 |
Management Effectiveness
| Return On Assets | -0.26 |
| Return On Equity | 3.27 |
Income Statement
| Revenue | 502.73M |
| Revenue/Share | 0.54 |
| Gross Profit | 76.44M |
| EBITDA | -42.52M |
| Net Income | -60.61M |
| Diluted EPS | -0.54 |
Balance Sheet
| Total Cash | 30.28M |
| Total Cash/Share | 0.03 |
| Total Debt | 26.25M |
| Total Debt/Equity | -1.61 |
| Current Ratio | 1.47 |
| Book Value Per Share | -0.02 |
Price History
| 52-Week Change | 41.23 |
| 52-Week High | 4.89 |
| 52-Week Low | 2.02 |
| Moving Average 50 Days | 3.7 |
| Moving Average 200 Days | 3.49 |
Statistics
| Average Volume | 1.86M |
| Shares Outstanding | 99.98M |
| % Held by Institutions | 4.2 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
